COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Asia Pacific Cochlear Implants Market would witness market growth of 11.4% CAGR during the forecast period (2019-2025). The Asia Pacific Cochlear Implants market is studied across the China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific. The China market dominated the Asia Pacific Cochlear Implants Market by Country 2018, thereby, achieving a market value of $200.7 million by 2025, growing at a CAGR of 9.1 % during the forecast period. The Japan market is expected to witness a CAGR of 12.4% during (2019 - 2025). Additionally, The India market is expected to witness a CAGR of 12.4% during (2019 - 2025).

Many developing nations are medical tourism’s preferred location. Asia is one of the most preferred locations for medical tourism, attracting more and more patients for treatment. For plastic surgery, weight loss surgery, cochlear operation, cardiovascular treatment, and orthopedic therapy, medical tourist visits Asia. Compared with advanced countries, the price of these surgical processes is relatively lower than in developing nations. More than 1,050,000+ healthcare tourists visited Malaysia for healthcare reasons in 2017, according to the Malaysia Healthcare Travel Council. India has also experienced a rapid rise in the amount of cochlear implant surgery clients coming to India.

Based on end-use, the adults’ segment was dominant in the market and the segment is projected to sustain this trend over the forecast period as well. The trend is attributable to the existence of a wide patient base and the increase in the geriatric population. Further, the pediatrics segment is projected to rise at a rapid pace over the years to come. Increased implantation at an early age and initiatives of several programs & government aid to deliver the cochlear implant to children at the earliest possible time are the key factors expected to propel the cochlear implants market.

Based on Fitting Type, the market is segmented into Unilateral Implantation and Bilateral Implantation. Based on End Use, the market is segmented into Pediatrics and Adults. Based on Country, the market is segmented into China, India, Japan, South Korea, Singapore, Malaysia and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MED-EL GmbH, Sonova Holding AG, William Demant Holding A/S, Starkey laboratories Inc., GN Store Nord A/S (GN Hearing A/S), Amplifon SpA (Ampliter N.V.), Widex A/S, Oticon Medical AB, Cochlear Ltd., Medtronic PLC.

Scope of the Study
Market Segmentation:
By Fitting Type

  • Unilateral Implantation
  • Bilateral Implantation


By End Use

  • Pediatrics
  • Adults


By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific


Companies Profiled

  • MED-EL GmbH
  • Sonova Holding AG
  • William Demant Holding A/S
  • Starkey laboratories, Inc.
  • GN Store Nord A/S (GN Hearing A/S)
  • Amplifon SpA (Ampliter N.V.)
  • Widex A/S
  • Oticon Medical AB
  • Cochlear Ltd.
  • Medtronic PLC


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free